1Y Close · As of Aug 26, 2026
HYUNDAI BIOSCIENCE operates in the Chemicals sector.
Legal name: HYUNDAI BIOSCIENCE CO., LTD.
In fiscal year 2025, HYUNDAI BIOSCIENCE (048410) reported revenue of 3.5 billion KRW, down 76.6% from 15.1 billion KRW a year earlier.
Operating profit was -18.2 billion KRW and net income was -22.1 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 635.0 billion KRW, with a P/B of 5.73.
These figures can be verified in the DART filing (receipt no. 20260330001311).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 3.5B | -18.2B | -22.1B |
| 2024 | 15.1B | 791M | -6.9B |
| 2023 | 9.5B | -9.8B | -14.5B |
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-13 | Semi-Annual Report (2026.06) |
| 2026-08-06 | Large Shareholding Report (General) |